About vericiguat micronized
Soluble guanylate cyclase stimulator
Used for
- Reduces risk of cardiovascular death and heart-failure hospitalization in adults with worsening chronic heart failure and reduced ejection fraction.
Usual adult dose
Start 2.5 mg once daily with food; double about every two weeks as tolerated to 10 mg once daily.
Common side effects
- Low blood pressure
- Anemia
- Dizziness
- Nausea
Important warnings
- Not for use during pregnancy; may harm an unborn baby.
- Avoid with other soluble guanylate cyclase stimulators, such as riociguat.
- Blood pressure can fall, especially with other blood-pressure-lowering medicines.
- Safety and effectiveness are not established in children.
Pregnancy
May cause fetal harm. Pregnancy testing and effective contraception are recommended during treatment and for one month afterward.
Breastfeeding
Unknown whether vericiguat passes into breast milk; effects on infants are unknown.
Interactions
- Other soluble guanylate cyclase stimulators, including riociguat, are contraindicated.
- Other medicines that lower blood pressure may increase hypotension risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.